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Over 1 million hernia repairs are performed annually in the United States, including
approximately 800,000 inguinal hernia repairs [1] and approximately 350,000 ventral/incisional
hernia operations [2]. Inguinal and ventral/incisional hernia recurrence following mesh repair
ranges from 0.5% to 10% with inguinal hernias [3] and 15% to 32% for ventral/incisional hernias [4].
These recurrence rates are improved when compared to historical tissue-based repairs. Prospective
trials of mesh vs. primary repair have also demonstrated decreased postoperative pain and shorter
hospital stay for mesh-based repairs [5]. Although different techniques of repair are practiced, no
particular mesh-repair technique has proven to be superior to others, especially with tension free
mesh-repairs.
In addition to the utility of mesh for hernia repairs, proposals for prophylactic implantation of
mesh following open abdominal surgeries, especially for the group of patients with a high risk of
incisional hernia formation, open a whole new prospect of an increased use of mesh in the future
[6]. The incentive for conducting an open-label, prospective randomized trial for evaluation of the
impact of prophylactic implantation of mesh stems from observations of high frequency of hernia
following abdominal surgeries and the fact that mesh is proven to be helpful with reducing the
recurrence of hernia following incisional hernia repair [6]. Given the current well-intentioned trend
toward limiting the use of mesh to forestall its complications, this voice for increasing the use of
mesh for prophylaxis begs for a comparison of the risk of mesh complications vs. the risks posed by
incisional hernias.

Current Mesh Limitations
Deficiencies of currently available meshes include operative factors such as handling time to
sterilely handle, measure, and cut/modify meshes intra-operatively, variable incidence of mesh
infections due to exposed mesh material to skin and outside environment, and difficulty with
placement of mesh and its fixation. Additional logistical factors include wasted mesh as excessive
mesh material is discarded, the shelf space requirements to stock different sizes and shapes of various
meshes, and shelf life limitations. It is clear that we are far from having an ideal mesh material and
application method. One solution for patient-specific hernia meshes have included the proposal of
3D printed meshes that allow for customization and even impregnation with drugs [7]. However, at
writing, this technology has not been implemented in human studies.

Proposed Mesh Sprayer Innovation
Given the limitations of currently available mesh and its placement, we propose a mesh
delivery model and a liquid, paste-like mesh. The current design includes a self-spraying device
that delivers liquid, paste-like, pressurized, sterile mesh in a controlled fashion (Figure 1 and 2).
The mesh would solidify shortly after exposure to the outside environment. The design allows for
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Figure 1: Components of proposed liquefied spray mesh delivery system.
This may be used with open operations (top images) along as a laparoscopic
or robotic instrumentation attachment (bottom image).

attachments to laparoscopic and robotic-assisted instruments or as
a free-standing attachment for open techniques. The liquefied mesh
reservoir can be deployed through the sprayer device, delivering the
solidifying compound in the place of the conventional placement of
currently available meshes for the repair of hernias. Additionally, the
spray device can be used prophylactically to facilitate fascial closure
for all abdominal surgical incisions. Of note, this technique requires
closure of fascia and, as such, cannot be used for bridging. The
contents of the spray reservoir are customizable, with the ability to
deliver permanent or bio-absorbable plastics, adhesives compounds,
or bioactive compounds. In our prior proof of concept publication,
we showed a novel system for attachment of a talc sprayer device to
the thoracoscopic camera which eliminated the angle which exists
in the current available systems between the camera and the sprayer
device (alpha angle). Eliminating this angle mitigates the uncertainty
and reduced accuracy when spraying talc during the thoracoscopic
procedures [8]. The same concept would apply to mesh spraying
devices.

Figure 2: Schematic of proposed liquefied mesh delivery system in an open
ventral hernia repair (A-E).
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property claims.
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